| Pfizer Inc. (PFE) | |||
|---|---|---|---|
| 37.05 -0.61 (-1.62%) | 11-20 16:03 | ||
| Open: | 37.57 | Pre. Close: | 37.66 |
| High: | 37.69 | Low: | 37.01 |
| Volume: | 14,571,853 | Market Cap: | 205039M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 37.778 - 37.964 | 37.964 - 38.115 |
| Low: | 36.492 - 36.747 | 36.747 - 36.953 |
| Close: | 36.697 - 37.079 | 37.079 - 37.388 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 44.27 One year: 45.48 |
| Support: | Support1: 36.22 Support2: 30.14 |
| Resistance: | Resistance1: 37.90 Resistance2: 38.94 |
| Pivot: | 37.34 |
| Moving Averages: | MA(5): 37.16  MA(20): 37.36 MA(100): 37.69 MA(250): 40.46 |
| MACD: | MACD(12,26): 0.12 Signal(12,26,9): 0.18 |
| %K %D: | %K(14,3): 39.02 %D(3): 36.28 |
| RSI: | RSI(14): 50.00 |
| 52-Week: | High: 46.47 Low: 33.97 Change(%): -14.0 |
| Average Vol(K): | 3-Month: 1893553 10-Days: 1940300 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.PFE has closed above bottom band by 36.8%. Bollinger Bands are 34.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
Thu, 21 Nov 2019 13:30:00 +0000 3 Top Healthcare Stocks to Buy in November Thu, 21 Nov 2019 12:00:00 +0000 1 Attractive Pharma Stock You Probably Haven't Heard Of Wed, 20 Nov 2019 14:28:09 +0000 Health Care Sector Update for 11/20/2019: JNJ, PFE, ABT, MRK, AMGN, ALC, BCRX, CRSP Wed, 20 Nov 2019 11:00:00 +0000 Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It. Fri, 15 Nov 2019 21:31:39 +0000 Dow Jones Today: Stocks Climb on U.S.-China Trade Developments |
| Financial Analysis | |
|---|---|
| Growth | |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency |  |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Major | |
| Shares Out. (M) | 5530.00 |
| Shares Float (M) | 5530.00 |
| % Held by Insiders | 0.03 |
| % Held by Institutions | 76.23 |
| Shares Short (K) | 47830 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | 2.830 |
| Book Value (p.s.) | 11.770 |
| PEG Ratio | 2.89 |
| Profit Margin | 30.57 |
| Operating Margin | 30.33 |
| Return on Assets (ttm) | 5.9 |
| Return on Equity (ttm) | 23.7 |
| Qtrly Rev. Growth | -4.6 |
| Gross Profit (p.s.) | 7.689 |
| Sales Per Share | |
| EBITDA (p.s.) | 4.038 |
| Qtrly Earnings Growth | 86.70 |
| Operating Cash Flow (M) | 13560.00 |
| Levered Free Cash Flow (M) | 11810.00 |
| Stock Valuation | |
|---|---|
| P/E | 13.09 |
| P/E Growth Ratio | -0.02 |
| P/BV | 3.15 |
| P/S | 3.93 |
| P/CF | 15.11 |
| Dividend Yield | 0.04 |
| Dividends & Splits | |
|---|---|
| Dividend | 1.420 |
| Dividend Pay Date | 2019-12-02 |
| Ex-Dividend Date | 2019-11-07 |
| Forward Dividend | 1.440 |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
